• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

转甲状腺素蛋白心脏淀粉样变患者的胸痛：一例报告

Chest pain in a patient with transthyretin cardiac amyloidosis: A case report.

作者信息

Xie Linfeng, Luo Suxin, Huang Bi

机构信息

Department of Cardiology the First Affiliated Hospital of Chongqing Medical University Chongqing China.

出版信息

Clin Case Rep. 2024 Apr 14;12(4):e8763. doi: 10.1002/ccr3.8763. eCollection 2024 Apr.

DOI:10.1002/ccr3.8763
PMID:38623359
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11016627/
Abstract

KEY CLINICAL MESSAGE

Patients with transthyretin cardiac amyloidosis (ATTR-CM) commonly present with dyspnea, fatigue, and edema. In our case, the main presentation was exertional angina, which was atypical in patients with ATTR-CM and should be paid more attention to.

ABSTRACT

A 54-year-old woman was admitted with a complaint of exertional chest pain, and she had a history of hypertension. The results of the electrocardiogram and echocardiography revealed the clues of cardiac amyloidosis, and the patient was finally diagnosed with transthyretin cardiac amyloidosis, then she received tafamidis, and the symptoms improved significantly.

摘要

关键临床信息

转甲状腺素蛋白心脏淀粉样变（ATTR-CM）患者通常表现为呼吸困难、疲劳和水肿。在我们的病例中，主要表现为劳力性心绞痛，这在ATTR-CM患者中不典型，应予以更多关注。

摘要

一名54岁女性因劳力性胸痛入院，有高血压病史。心电图和超声心动图结果揭示了心脏淀粉样变的线索，该患者最终被诊断为转甲状腺素蛋白心脏淀粉样变，随后接受了氯苯唑酸治疗，症状显著改善。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e85/11016627/57627071c875/CCR3-12-e8763-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e85/11016627/076a4c5de792/CCR3-12-e8763-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e85/11016627/e52fb3ed6535/CCR3-12-e8763-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e85/11016627/0a081eeda354/CCR3-12-e8763-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e85/11016627/5a29392c50bf/CCR3-12-e8763-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e85/11016627/7aa9cb5398bf/CCR3-12-e8763-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e85/11016627/57627071c875/CCR3-12-e8763-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e85/11016627/076a4c5de792/CCR3-12-e8763-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e85/11016627/e52fb3ed6535/CCR3-12-e8763-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e85/11016627/0a081eeda354/CCR3-12-e8763-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e85/11016627/5a29392c50bf/CCR3-12-e8763-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e85/11016627/7aa9cb5398bf/CCR3-12-e8763-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e85/11016627/57627071c875/CCR3-12-e8763-g006.jpg

相似文献

1
Chest pain in a patient with transthyretin cardiac amyloidosis: A case report.转甲状腺素蛋白心脏淀粉样变患者的胸痛：一例报告
Clin Case Rep. 2024 Apr 14;12(4):e8763. doi: 10.1002/ccr3.8763. eCollection 2024 Apr.
2
Optimal Echocardiographic Parameters to Improve the Diagnostic Yield of Tc-99m-Bone Avid Tracer Cardiac Scintigraphy for Transthyretin Cardiac Amyloidosis.优化超声心动图参数以提高 Tc-99m-骨亲合示踪剂心肌闪烁显像诊断转甲状腺素蛋白心脏淀粉样变性的诊断率。
Circ Cardiovasc Imaging. 2022 Nov;15(11):e014645. doi: 10.1161/CIRCIMAGING.122.014645. Epub 2022 Nov 15.
3
Reverse cardiac remodelling and dysfunction in A97S transthyretin cardiac amyloidosis after tafamidis treatment.特立氟胺治疗后 A97S 转甲状腺素蛋白心脏淀粉样变的心脏逆重构和功能障碍。
ESC Heart Fail. 2022 Dec;9(6):4335-4339. doi: 10.1002/ehf2.14165. Epub 2022 Sep 20.
4
Hereditary cardiac amyloidosis associated with Pro24Ser transthyretin mutation: a case report.与Pro24Ser转甲状腺素蛋白突变相关的遗传性心脏淀粉样变性：一例报告
J Med Case Rep. 2018 Dec 16;12(1):370. doi: 10.1186/s13256-018-1931-5.
5
The Association of Cardiac Biomarkers, the Intensity of Tc99 Pyrophosphate Uptake, and Survival in Patients Evaluated for Transthyretin Cardiac Amyloidosis in the Early Therapeutics Era.在早期治疗时代，评估转甲状腺素蛋白心脏淀粉样变性患者的心脏生物标志物、Tc99 焦磷酸盐摄取强度与生存的关系。
J Card Fail. 2022 Oct;28(10):1509-1518. doi: 10.1016/j.cardfail.2022.06.005. Epub 2022 Jul 14.
6
Technetium-99m-pyrophosphate imaging-based computed tomography-guided core-needle biopsy of internal oblique muscle in wild-type transthyretin cardiac amyloidosis.基于 99mTc-焦磷酸盐的计算机断层扫描引导下对野生型转甲状腺素蛋白心脏淀粉样变性患者内斜肌进行芯针活检。
Amyloid. 2024 Mar;31(1):12-21. doi: 10.1080/13506129.2023.2235881. Epub 2023 Jul 24.
7
Myocardial Scintigraphy in Diagnosing Cardiac Transthyretin Amyloidosis.心肌闪烁显像诊断心脏转甲状腺素淀粉样变性。
Tex Heart Inst J. 2022 Jul 1;49(4). doi: 10.14503/THIJ-20-7379.
8
Tafamidis decreased cardiac amyloidosis deposition in patients with Ala97Ser hereditary transthyretin cardiomyopathy: a 12-month follow-up cohort study.他法米替尼可降低 Ala97Ser 遗传性转甲状腺素蛋白心肌病患者的心脏淀粉样变性沉积：一项为期 12 个月的随访队列研究。
Orphanet J Rare Dis. 2023 Sep 13;18(1):289. doi: 10.1186/s13023-023-02824-0.
9
Physical Examination as a Clue to Transthyretin Cardiac Amyloidosis: A Case Report.体格检查作为转甲状腺素蛋白心脏淀粉样变的线索：一例报告
Cureus. 2023 Aug 3;15(8):e42925. doi: 10.7759/cureus.42925. eCollection 2023 Aug.
10
Technetium-pyrophosphate scintigraphy: a practical guide for early diagnosis of transthyretin amyloid cardiomyopathy.锝焦磷酸盐闪烁扫描术：转甲状腺素淀粉样变心肌病早期诊断的实用指南。
ESC Heart Fail. 2022 Feb;9(1):251-262. doi: 10.1002/ehf2.13693. Epub 2021 Nov 29.

引用本文的文献

1
A Case Report and Literature Review of Cardiac Amyloidosis: The Great Pretender Masquerading As Acute Coronary Syndrome.心脏淀粉样变性病例报告及文献综述：伪装成急性冠状动脉综合征的“伪装者”
Cureus. 2025 Apr 1;17(4):e81567. doi: 10.7759/cureus.81567. eCollection 2025 Apr.

本文引用的文献

1
Microvascular cardiac amyloidosis-Cardiac involvement of amyloidosis presenting as typical chest pain.微血管性心肌淀粉样变——以典型胸痛为表现的淀粉样变性的心脏受累。
Am J Hematol. 2023 Dec;98(12):1963-1966. doi: 10.1002/ajh.27122. Epub 2023 Oct 25.
2
Chest pain in cardiac amyloidosis: occurrence, causes and prognostic significance.心脏淀粉样变中的胸痛：发生、原因和预后意义。
Int J Cardiol. 2023 Oct 15;389:131204. doi: 10.1016/j.ijcard.2023.131204. Epub 2023 Jul 21.
3
Exertional chest pain is sometimes more than just coronary atherosclerosis.
运动相关性胸痛有时不仅仅是冠状动脉粥样硬化。
Rev Port Cardiol (Engl Ed). 2021 Mar;40(3):245.e1-245.e5. doi: 10.1016/j.repc.2021.02.002. Epub 2021 Mar 11.
4
Cardiac amyloidosis masquerading as acute coronary syndrome.心肌淀粉样变性伪装为急性冠状动脉综合征。
BMJ Case Rep. 2021 Feb 18;14(2):e238499. doi: 10.1136/bcr-2020-238499.
5
Cardiac amyloidosis mimicking acute coronary syndrome: a case report and literature review.酷似急性冠状动脉综合征的心脏淀粉样变性：一例报告及文献综述
Eur Heart J Case Rep. 2020 Oct 29;4(6):1-7. doi: 10.1093/ehjcr/ytaa325. eCollection 2020 Dec.
6
Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart Association.心脏淀粉样变性：不断发展的诊断和治疗——美国心脏协会的科学声明。
Circulation. 2020 Jul 7;142(1):e7-e22. doi: 10.1161/CIR.0000000000000792. Epub 2020 Jun 1.
7
Screening for Transthyretin Amyloid Cardiomyopathy in Everyday Practice.在日常实践中筛查转甲状腺素蛋白淀粉样心肌病。
JACC Heart Fail. 2019 Aug;7(8):709-716. doi: 10.1016/j.jchf.2019.04.010. Epub 2019 Jul 10.
8
Intramural Coronary Amyloidosis Mimicking Effort Angina Pectoris Preceding Fatal Heart Failure.
Circ J. 2019 Mar 25;83(4):837. doi: 10.1253/circj.CJ-18-0180. Epub 2018 Sep 8.
9
Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging: Predicting Survival for Patients With ATTR Cardiac Amyloidosis.多中心研究 99mTc 焦磷酸盐平面心肌显像术：预测ATTR 心脏淀粉样变性患者的生存率。
JAMA Cardiol. 2016 Nov 1;1(8):880-889. doi: 10.1001/jamacardio.2016.2839.
10
Genotype and Phenotype of Transthyretin Cardiac Amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey).转甲状腺素蛋白心脏淀粉样变性的基因型与表型：THAOS（转甲状腺素蛋白淀粉样变性结局调查）
J Am Coll Cardiol. 2016 Jul 12;68(2):161-72. doi: 10.1016/j.jacc.2016.03.596.